Skip to content
DataLookout
Menu

NCT05018871

Safety of Cultured Umbilical or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for CP

StatusWithdrawn
PhasePhase 1
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

See every version on ClinicalTrials.gov ↗

  1. Stopped Trial status changed: Recruiting → Withdrawn Sponsor's reason: Duplicate registration; study is registered and actively tracked under NCT05018819. No participants were enrolled under this record.
  2. Stopped Trial status: Recruiting to Suspendedv2
  • Stopped: terminated, suspended or withdrawn

Endpoints

Primary

Safety (adverse events)
Timeframe: Four year follow-up

Secondary (1)

Efficacy: Gross Motor Function Measure (GMFM)

Arms and interventions

Treatment GroupExperimental

Single intravenous infusion of 100 million cells

Biologicals: Umbilical or placental derived mesenchymal stem cells

Sites

2 sites in 2 countries

Greece 1, United States 1